Ozkaynak MF - Search Results

1

Pharmacology studies of 1-beta-D-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug.

Avramis VI, Weinberg KI, Sato JK, Lenarsky C, Willoughby ML, Coates TD, Ozkaynak MF, Parkman R. Avramis VI, et al. Among authors: ozkaynak mf. Cancer Res. 1989 Jan 1;49(1):241-7. Cancer Res. 1989. PMID: 2908850

2

In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide.

Ozkaynak MF, Nolta J, Parkman R. Ozkaynak MF, et al. Cancer Res. 1990 Mar 1;50(5):1455-8. Cancer Res. 1990. PMID: 2302710

3

Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.

Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C. Ozkaynak MF, et al. Bone Marrow Transplant. 1991 Jun;7(6):467-74. Bone Marrow Transplant. 1991. PMID: 1908340

4

Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia.

Ozkaynak MF, Avramis VI, Carcich S, Ortega JA. Ozkaynak MF, et al. Med Pediatr Oncol. 1998 Dec;31(6):475-82. doi: 10.1002/(sici)1096-911x(199812)31:6<475::aid-mpo3>3.0.co;2-7. Med Pediatr Oncol. 1998. PMID: 9835899

5

Mycobacterium avium-intracellulare infections after allogeneic bone marrow transplantation in children.

Ozkaynak MF, Lenarsky C, Kohn D, Weinberg K, Parkman R. Ozkaynak MF, et al. Am J Pediatr Hematol Oncol. 1990 Summer;12(2):220-4. doi: 10.1097/00043426-199022000-00019. Am J Pediatr Hematol Oncol. 1990. PMID: 2378416

6

Triple X chromosome constitution and acute nonlymphocytic leukemia.

Ozkaynak MF, Ying KL, Laug WE. Ozkaynak MF, et al. Cancer Genet Cytogenet. 1988 Oct 1;35(1):1-3. doi: 10.1016/0165-4608(88)90114-8. Cancer Genet Cytogenet. 1988. PMID: 3179999

7

The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia.

Carr E, Jayabose S, Stringel G, Slim M, Ozkaynak MF, Tugal O, Sandoval C. Carr E, et al. Among authors: ozkaynak mf. Pediatr Blood Cancer. 2006 Dec;47(7):886-8. doi: 10.1002/pbc.20629. Pediatr Blood Cancer. 2006. PMID: 16200633

8

The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia.

Hochberg J, Zahler S, Geyer MB, Chen N, Krajewski J, Harrison L, Militano O, Ozkaynak MF, Cheerva AC, Talano J, Moore TB, Gillio AP, Walters MC, Baxter-Lowe LA, Hamby C, Cairo MS. Hochberg J, et al. Among authors: ozkaynak mf. Bone Marrow Transplant. 2019 Feb;54(2):226-235. doi: 10.1038/s41409-018-0247-9. Epub 2018 Jun 13. Bone Marrow Transplant. 2019. PMID: 29899571 Clinical Trial.

9

Cytogenetic abnormalities during clinical, immunophenotypic, and molecular remission in pediatric acute lymphoblastic leukemia.

Sandoval C, Mayer SP, Giamelli J, Farley T, Ozkaynak MF, Tugal O, Jayabose S. Sandoval C, et al. Among authors: ozkaynak mf. Cancer Genet Cytogenet. 2000 Apr 1;118(1):9-13. doi: 10.1016/s0165-4608(99)00161-2. Cancer Genet Cytogenet. 2000. PMID: 10731583

10

Trisomy 5 as a sole cytogenetic abnormality in pediatric acute lymphoblastic leukemia.

Sandoval C, Mayer SP, Ozkaynak MF, Tugal O, Jayabose S. Sandoval C, et al. Among authors: ozkaynak mf. Cancer Genet Cytogenet. 2000 Apr 1;118(1):69-71. doi: 10.1016/s0165-4608(99)00176-4. Cancer Genet Cytogenet. 2000. PMID: 10731595 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters